ID

17653

Descrizione

Sponsor: OSI Pharmaceuticals Information provided by (Responsible Party): Astellas Pharma Inc ( OSI Pharmaceuticals ) A multicenter, randomized, double-blind, placebo-controlled, phase 3 study of single-agent Tarceva® (erlotinib) following complete tumor resection with or without adjuvant chemotherapy in patients with stage IB-IIIA non-small cell lung carcinoma who have EGFR-positive tumors. See https://clinicaltrials.gov/ct2/show/NCT00373425 Part: Withdrawal of Consent

collegamento

https://clinicaltrials.gov/ct2/show/NCT00373425

Keywords

versioni (2)
  1. 02/08/16 02/08/16 -
  2. 27/09/16 27/09/16 -
Caricato su

27 settembre 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Withdrawal of Consent, Tarceva in NSCLC patients who have EGFR-positive tumors DRKS00001485 NCT00373425

Inglese

Withdrawal of Consent, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425

1 moduli  
Withdrawal of Treatment Consent
Descrizione

Withdrawal of Treatment Consent

Withdrawal of Treatment Consent: Not Applicable
Descrizione

Withdrawal of Treatment Consent

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0087111
Patient withdrew treatment consent during the study. Date:
Descrizione

Date Consent Withdrawn

Tipo di dati

date

Alias
UMLS CUI [1,1]
C1707492
UMLS CUI [1,2]
C0011008
Withdrawal of Tissue Consent
Descrizione

Withdrawal of Tissue Consent

Withdrawal of Tissue Consent: Not Applicable
Descrizione

Withdrawal of Tissue Consent

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0475358
Patient withdrew tumor tissue consent during the study. Date:
Descrizione

Date Consent Withdrawn

Tipo di dati

date

Alias
UMLS CUI [1,1]
C1707492
UMLS CUI [1,2]
C0011008
Withdrawal of Optional Research Blood Sample Consent
Descrizione

Withdrawal of Optional Research Blood Sample Consent

Withdrawal of Optional Research Blood Sample Consent: Not Applicable
Descrizione

Withdrawal of Optional Research Blood Sample Consent

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0178913
Patient withdrew optional blood sample consent during the study. Date:
Descrizione

Date Consent Withdrawn

Tipo di dati

date

Alias
UMLS CUI [1,1]
C1707492
UMLS CUI [1,2]
C0011008
Investigator Signature
Descrizione

Investigator Signature

Investigator's Signature
Descrizione

Investigator Signature

Tipo di dati

text

Alias
UMLS CUI [1]
C2346576
Signature Date
Descrizione

Signature date

Tipo di dati

date

Alias
UMLS CUI [1]
C0807937
Ritorna all'inizio della pagina

Similar models

Withdrawal of Consent, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Withdrawal of Treatment Consent
Withdrawal of Treatment Consent
Item
Withdrawal of Treatment Consent: Not Applicable
boolean
C0021430 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
Date Consent Withdrawn
Item
Patient withdrew treatment consent during the study. Date:
date
C1707492 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item Group
Withdrawal of Tissue Consent
Withdrawal of Tissue Consent
Item
Withdrawal of Tissue Consent: Not Applicable
boolean
C0021430 (UMLS CUI [1,1])
C0475358 (UMLS CUI [1,2])
Date Consent Withdrawn
Item
Patient withdrew tumor tissue consent during the study. Date:
date
C1707492 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item Group
Withdrawal of Optional Research Blood Sample Consent
Withdrawal of Optional Research Blood Sample Consent
Item
Withdrawal of Optional Research Blood Sample Consent: Not Applicable
boolean
C0021430 (UMLS CUI [1,1])
C0178913 (UMLS CUI [1,2])
Date Consent Withdrawn
Item
Patient withdrew optional blood sample consent during the study. Date:
date
C1707492 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item Group
Investigator Signature
Investigator Signature
Item
Investigator's Signature
text
C2346576 (UMLS CUI [1])
Signature date
Item
Signature Date
date
C0807937 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial